A detailed history of Re Dickinson Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Re Dickinson Investment Advisors, LLC holds 2,152 shares of AMGN stock, worth $566,793. This represents 0.4% of its overall portfolio holdings.

Number of Shares
2,152
Previous 2,152 -0.0%
Holding current value
$566,793
Previous $672,000 3.13%
% of portfolio
0.4%
Previous 0.42%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$229.03 - $291.01 $2,290 - $2,910
-10 Reduced 0.46%
2,152 $565,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $429,978 - $492,071
2,162 New
2,162 $486,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Re Dickinson Investment Advisors, LLC Portfolio

Follow Re Dickinson Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Re Dickinson Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Re Dickinson Investment Advisors, LLC with notifications on news.